SGH bought Rovipharm and RR Plastiques to boost its capacity to make delivery systems for liquid medicines.

A Google AI accurately predicted patients’ risk of death during hospital stays using raw data from the entirety of their electronic health record.

Medtronic rolled out an updated meal-logging app for its iPro2 glucose-monitoring device.

Organ-chip developer Emulate gathered $36 million in VC financing and plans to include a wider range of diseases in its models for drug testing.

The deal will further Roche’s precision medicine plans while allowing Foundation to retain autonomy and continue to work with other biopharmas.

The FDA cleared DreaMed’s decision support software for managing Type 1 diabetes in patients that use insulin pumps and continuous glucose monitoring.

PerkinElmer designed the tests to run on its automated EUROPattern microscope, thereby cutting turnaround times.

Adopting new diagnostic tests could help the U.K.’s National Health Service save more than $8 billion in five years.

A federal grand jury has indicted Theranos CEO Elizabeth Holmes and former COO Sunny Balwani for several counts of wire fraud.

An FDA advisory committee panel voted against recommending premarket approval for PneumRx’s Elevair lung implant for patients with severe emphysema.